EP Patent

EP2078711A1 — (Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor

Assigned to Angelini Acraf SpA · Expires 2009-07-15 · 17y expired

What this patent protects

An (aza)indole derivative substituted in position 5, of formula (I): in which X, Y, Z, G1, G2, G3, R1, W, and R2 have the meanings given in the description, a pharmaceutical composition comprising it, and also intermediate compounds and a preparation process therefor.

USPTO Abstract

An (aza)indole derivative substituted in position 5, of formula (I): in which X, Y, Z, G1, G2, G3, R1, W, and R2 have the meanings given in the description, a pharmaceutical composition comprising it, and also intermediate compounds and a preparation process therefor.

Drugs covered by this patent

Patent Metadata

Patent number
EP2078711A1
Jurisdiction
EP
Classification
Expires
2009-07-15
Drug substance claim
No
Drug product claim
No
Assignee
Angelini Acraf SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.